PL2814508T3 - Szczepionki podjednostkowe przeciw rotawirusom oraz sposoby ich wytwarzania i zastosowania - Google Patents

Szczepionki podjednostkowe przeciw rotawirusom oraz sposoby ich wytwarzania i zastosowania

Info

Publication number: PL2814508T3
Authority: PL; Poland
Prior art keywords: making; methods; subunit vaccines; rotavirus subunit; rotavirus
Prior art date: 2012-02-14

Application number

PL13706871T

Other languages

English (en)

Inventor

Russell F. Bey

Randy R. Simonson

Kamesh Reddy Sirigireddy

Benjamin Matthew Hause

Original Assignee

Merial, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-02-14

Filing date

2013-02-14

Publication date

2017-09-29

2013-02-14 Application filed by Merial, Inc. filed Critical Merial, Inc.

2017-09-29 Publication of PL2814508T3 publication Critical patent/PL2814508T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

PL13706871T 2012-02-14 2013-02-14 Szczepionki podjednostkowe przeciw rotawirusom oraz sposoby ich wytwarzania i zastosowania PL2814508T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201261598624P	2012-02-14	2012-02-14

Publications (1)

Publication Number	Publication Date
PL2814508T3 true PL2814508T3 (pl)	2017-09-29

Family

ID=47755047

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13706871T PL2814508T3 (pl)	2012-02-14	2013-02-14	Szczepionki podjednostkowe przeciw rotawirusom oraz sposoby ich wytwarzania i zastosowania

Country Status (21)

Country	Link
US (1)	US9446117B2 (pl)
EP (1)	EP2814508B1 (pl)
JP (1)	JP6149240B2 (pl)
KR (1)	KR102087458B1 (pl)
CN (1)	CN104203274B (pl)
AR (2)	AR089995A1 (pl)
AU (1)	AU2013221479B2 (pl)
BR (1)	BR112014020025B1 (pl)
CA (1)	CA2864106C (pl)
DK (1)	DK2814508T5 (pl)
EA (1)	EA034564B1 (pl)
ES (1)	ES2632429T3 (pl)
HU (1)	HUE033858T2 (pl)
LT (1)	LT2814508T (pl)
MX (1)	MX353786B (pl)
NZ (1)	NZ628282A (pl)
PH (1)	PH12014501795B1 (pl)
PL (1)	PL2814508T3 (pl)
PT (1)	PT2814508T (pl)
SI (1)	SI2814508T1 (pl)
WO (1)	WO2013123219A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10004797B2 (en)	2010-10-27	2018-06-26	Harrisvaccines, Inc.	Method of rapidly producing improved vaccines for animals
RU2649132C1 (ru) *	2017-08-03	2018-03-29	Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства	Способ получения активного начала вакцины против ротавирусной инфекции белка FliCVP6VP8
CN108864260A (zh) *	2018-07-17	2018-11-23	昆明学院	非结构蛋白nsp4、重组杆状病毒液及制备、粘膜佐剂
CN109306007B (zh) *	2018-09-26	2021-10-08	华中农业大学	抗猪繁殖与呼吸综合征病毒nsp4蛋白基因工程抗体及应用
US20220160864A1 (en) *	2020-10-05	2022-05-26	Boehringer Ingelheim Animal Health USA Inc.	Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof
CA3195910A1 (en) *	2020-10-05	2022-04-14	Boehringer Ingelheim Vetmedica Gmbh	Fusion protein useful for vaccination against rotavirus
CN114875047A (zh) *	2022-05-27	2022-08-09	江苏三仪生物工程有限公司	一种优化的猪轮状病毒外衣壳蛋白vp4的重组表达及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
CA1247080A (en)	1983-03-08	1988-12-20	Commonwealth Serum Laboratories Commission	Antigenically active amino acid sequences
EP0173552B1 (en)	1984-08-24	1991-10-09	The Upjohn Company	Recombinant dna compounds and the expression of polypeptides such as tpa
US5186933A (en)	1986-12-30	1993-02-16	Baylor College Of Medicine	Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
US5147639A (en) *	1990-06-19	1992-09-15	Ambico, Inc.	Type-c rotavirus cultures and uses therefor
US5298244A (en)	1990-10-25	1994-03-29	University Of Saskatchewan	Assembled viral particles and their use in a vaccine to rotaviral disease
BE1006085A3 (fr)	1992-07-31	1994-05-10	Univ Bruxelles	Vecteur de clonage.
JPH11504631A (ja)	1995-04-25	1999-04-27	バイカルインコーポレイテッド	Ｄｎａ／脂質複合体の単一バイアル製剤
US6673355B1 (en)	1995-06-14	2004-01-06	Baylor College Of Medicine	Rotavirus enterotoxin NSP4 and methods of using same
WO1997000088A2 (en) *	1995-06-14	1997-01-03	Baylor College Of Medicine	Rotavirus enterotoxin nsp4 and methods of using same
US5846946A (en)	1996-06-14	1998-12-08	Pasteur Merieux Serums Et Vaccins	Compositions and methods for administering Borrelia DNA
FR2751225B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique aviaire
FR2751226B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751224B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751227B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751229B1 (fr)	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751228B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Vaccin polynucleotidique bovin pour voie intradermique
ATE292980T1 (de)	1996-10-11	2005-04-15	Univ California	Immunostimulierende oligonucleotidekonjugate
AU8444798A (en)	1997-06-30	1999-01-25	Centre National De La Recherche Scientifique	Improved method for transferring nucleic acid into the striped muscle and combination therefor
CA2327387C (en)	1998-05-07	2012-07-03	Gx Biosystems A/S	Cytotoxin-based biological containment
FR2778858B1 (fr)	1998-05-20	2000-06-16	Oreal	Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
US6716431B1 (en)	1998-05-29	2004-04-06	Wyeth Holdings Corporation	Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
US6187319B1 (en)	1998-06-01	2001-02-13	University Of Massachusetts	Cross-protective rotavirus vaccine
US6589529B1 (en)	1998-10-30	2003-07-08	Children's Hospital Medical Center	Rotavirus subunit vaccine
FR2801607B1 (fr)	1999-11-26	2001-12-28	Merial Sas	Pneumovirus du canard et vaccins correspondants
US6852705B2 (en)	2000-01-21	2005-02-08	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US6867353B2 (en)	2000-02-12	2005-03-15	Exploregen Inc.	Production method of recombinant rotavirus structural proteins and vaccine composition
CA2427809A1 (en) *	2000-11-03	2002-05-10	Baylor College Of Medicine	Rotavirus enterotoxin nsp4 and methods of using same
CA2510189A1 (en)	2002-12-19	2004-07-08	Thomas Gore	Trivalent vaccine with maternal antibody transfer via the milk
US7371395B2 (en) *	2003-07-24	2008-05-13	Merial Limited	Vaccine formulations
WO2006007555A2 (en) *	2004-07-01	2006-01-19	Children's Medical Center Corporation ¨	Rotavirus antigens
US7691368B2 (en) *	2005-04-15	2010-04-06	Merial Limited	Vaccine formulations
BRPI0504441A (pt)	2005-10-20	2007-06-26	Fundacao Oswaldo Cruz	vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico
EP1991262A4 (en) *	2006-03-03	2009-11-04	Merial Ltd	MYCOPLASMA HYOPNEUMONIAE VACCINE
EP2297186B1 (en)	2008-05-29	2018-08-29	The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services,	Expression and assembly of human group c rotavirus-like particles and uses thereof
CA2730741C (en)	2008-07-18	2016-10-25	Regis Sodoyer	Self-replicating vector lacking an antibiotic-resistance gene
UA107940C2 (en)	2009-09-10	2015-03-10	Merial Ltd	The vaccine composition that includes the saponin-containing adjuvant

2013
- 2013-02-14 SI SI201330696T patent/SI2814508T1/sl unknown
- 2013-02-14 KR KR1020147025474A patent/KR102087458B1/ko active Active
- 2013-02-14 EP EP13706871.4A patent/EP2814508B1/en active Active
- 2013-02-14 AU AU2013221479A patent/AU2013221479B2/en active Active
- 2013-02-14 CN CN201380015512.9A patent/CN104203274B/zh active Active
- 2013-02-14 AR ARP130100465A patent/AR089995A1/es active IP Right Grant
- 2013-02-14 ES ES13706871.4T patent/ES2632429T3/es active Active
- 2013-02-14 MX MX2014009722A patent/MX353786B/es active IP Right Grant
- 2013-02-14 EA EA201400914A patent/EA034564B1/ru unknown
- 2013-02-14 JP JP2014557775A patent/JP6149240B2/ja active Active
- 2013-02-14 NZ NZ628282A patent/NZ628282A/en unknown
- 2013-02-14 PT PT137068714T patent/PT2814508T/pt unknown
- 2013-02-14 PL PL13706871T patent/PL2814508T3/pl unknown
- 2013-02-14 LT LTEP13706871.4T patent/LT2814508T/lt unknown
- 2013-02-14 BR BR112014020025-4A patent/BR112014020025B1/pt active IP Right Grant
- 2013-02-14 WO PCT/US2013/026179 patent/WO2013123219A1/en not_active Ceased
- 2013-02-14 HU HUE13706871A patent/HUE033858T2/en unknown
- 2013-02-14 DK DK13706871.4T patent/DK2814508T5/da active
- 2013-02-14 CA CA2864106A patent/CA2864106C/en active Active
- 2013-02-14 US US13/767,569 patent/US9446117B2/en active Active
2014
- 2014-08-08 PH PH12014501795A patent/PH12014501795B1/en unknown
2022
- 2022-07-22 AR ARP220101959A patent/AR126891A2/es unknown

Also Published As

Publication number	Publication date
CN104203274A (zh)	2014-12-10
PH12014501795B1 (en)	2019-06-14
PH12014501795A1 (en)	2014-11-17
JP6149240B2 (ja)	2017-06-21
CN104203274B (zh)	2017-09-08
AR126891A2 (es)	2023-11-29
EA201400914A1 (ru)	2014-12-30
HK1200326A1 (en)	2015-08-07
SI2814508T1 (sl)	2017-10-30
AU2013221479B2 (en)	2017-06-08
HUE033858T2 (en)	2018-01-29
AU2013221479A1 (en)	2014-08-28
MX353786B (es)	2018-01-29
ES2632429T3 (es)	2017-09-13
EP2814508B1 (en)	2017-04-12
US20130209507A1 (en)	2013-08-15
EA034564B1 (ru)	2020-02-20
PT2814508T (pt)	2017-07-19
DK2814508T3 (da)	2017-05-22
EP2814508A1 (en)	2014-12-24
JP2015508776A (ja)	2015-03-23
DK2814508T5 (da)	2017-06-12
BR112014020025B1 (pt)	2022-09-27
MX2014009722A (es)	2015-02-20
KR102087458B1 (ko)	2020-03-10
US9446117B2 (en)	2016-09-20
CA2864106A1 (en)	2013-08-22
CA2864106C (en)	2017-10-17
WO2013123219A1 (en)	2013-08-22
BR112014020025A2 (pt)	2017-07-04
LT2814508T (lt)	2017-06-26
BR112014020025A8 (pt)	2022-07-12
AR089995A1 (es)	2014-10-01
NZ628282A (en)	2016-08-26
KR20140123592A (ko)	2014-10-22

Publication	Publication Date	Title
IL268976B (en)	2021-04-29	Intraocular implants comprising prostamide and methods of using them
GB2535360B (en)	2017-04-12	Methods of preparing polyhemiaminals and polyhexahydrotriazines
ZA201408236B (en)	2016-01-27	Anti-ly6e antibodies and immunoconjugates and methods of use
ZA201501858B (en)	2016-11-30	Anti-mcam antibodies and associated methods of use
EP2844903A4 (en)	2015-12-23	TUBES AND METHOD FOR THE PRODUCTION AND USE THEREOF
ZA201404675B (en)	2016-11-30	Anti-lrp5 antibodies and methods of use
SG11201502757QA (en)	2015-05-28	Anti-c16orf54 antibodies and methods of use thereof
IL230855A0 (en)	2014-03-31	Cabazitaxel formulations and methods for their preparation
EP2806811A4 (en)	2016-05-18	VERTEBRAL CONSTRUCTION
HRP20181704T1 (hr)	2018-12-28	Kristalni oblik kidamida, metoda pripreme i uporabe istog
IL234906A0 (en)	2014-12-31	Colchicine compositions, methods of production and methods of using them
LT2814508T (lt)	2017-06-26	Rotaviruso subvieneto vakcinos jų gamybos būdai ir panaudojimas
ZA201409124B (en)	2017-05-31	Reassortant btv and ahsv vaccines
PL2874656T3 (pl)	2018-04-30	Atenuowane szczepionki przeciw grypie świń oraz ich sposoby wytwarzania i zastosowanie
PL2631024T3 (pl)	2021-11-08	Preformy odlewnicze oraz sposoby ich stosowania
ZA201408128B (en)	2015-12-23	Etract of greyia radlkoferi and use thereof